Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments.

Antibiotics (Basel)

Molecular Medicine Laboratory, Unidad Academica de Medicina Humana y Ciencias de la Salud, Universidad Autonoma de Zacatecas, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, C.P. 98160 Zacatecas, Mexico.

Published: October 2019

Diabetic foot ulcers (DFUs) are very important diabetes-related lesions that can lead to serious physical consequences like amputations of limbs and equally severe social, psychological, and economic outcomes. It is reported that up to 25% of patients with diabetes develop a DFU in their lifetime, and more than half of them become infected. Therefore, it is essential to manage infection and ulcer recovery to prevent negatives outcomes. The available information plays a significant role in keeping both physicians and patients aware of the emerging therapies against DFUs. The purpose of this review is to compile the currently available approaches in the managing and treatment of DFUs, including molecular and regenerative medicine, antimicrobial and energy-based therapies, and the use of plant extracts, antimicrobial peptides, growth factors, ozone, devices, and nano-medicine, to offer an overview of the assessment of this condition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963879PMC
http://dx.doi.org/10.3390/antibiotics8040193DOI Listing

Publication Analysis

Top Keywords

diabetic foot
8
foot ulcers
8
ulcers current
4
current advances
4
advances antimicrobial
4
antimicrobial therapies
4
therapies emerging
4
emerging treatments
4
treatments diabetic
4
ulcers dfus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!